Each week we highlight five things affecting the life sciences industry. Here's the latest. Biotech CEOs discuss the highs and lows of a successful IPO Speaking at a conference last week, CEOs of three biotechs that closed initial public offerings in 2024 spoke about the process of managing an IPO ... READ MORE >
5 things to know in life sciences: Week of Feb. 10, 2025
Each week we highlight five things affecting the life sciences industry. Here's the latest. GLP-1 drugs may limit patients’ alcohol use Emerging research suggests GLP-1 drugs may help reduce alcohol cravings, with a small Phase 2 trial showing participants with alcohol use disorder cut their ... READ MORE >
5 things to know in life sciences: Week of Feb. 3, 2025
Each week we highlight five things affecting the life sciences industry. Here's the latest. Possible tariffs could affect prescription drug costs and availability Pharmaceutical groups warn that recent proposed tariffs on imports from China, Canada and Mexico could lead to higher prices and ... READ MORE >
5 things to know in life sciences: Week of Jan. 27, 2025
Each week we highlight five things affecting the life sciences industry. Here's the latest. Funding freeze sparks chaos in U.S. scientific research The Medicine Maker reports that a temporary federal funding freeze initiated by the Trump administration caused panic among researchers and nonprofit ... READ MORE >
5 things to know in life sciences: Week of Jan. 20, 2025
Each week we highlight five things affecting the life sciences industry. Here's the latest. Four trends relating to AI in medtech MedTech Dive highlighted four key issues to monitor this year including: new FDA guidance, payer hesitancy to artificial intelligence-backed products, the new focus on use of ... READ MORE >
5 things to know in life sciences: Week of Jan. 13, 2025
Each week we highlight five things affecting the life sciences industry. Here's the latest. J.P. Morgan Healthcare Conference highlights Key discussions on the first day of the J.P. Morgan Healthcare Conference focused on innovation, partnerships and market trends, reports Fierce Pharma. Industry ... READ MORE >
5 things to know in life sciences: Week of Jan. 6, 2025
Each week we highlight five things affecting the life sciences industry. Here's the latest. Small biopharma companies drive 2024 drug approvals Small companies led the way with 55 new drug and biologic approvals, reflecting a trend of biotechs resisting buyouts and opting to market their products ... READ MORE >
5 things to know in life sciences: Week of Dec. 16, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Manufacturing takes center stage in biopharma In 2024, biopharma companies prioritized manufacturing capabilities to attract investors and ensure scalability, as reported by BioSpace. Major companies are ... READ MORE >
5 things to know in life sciences: Week of December 9, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FTC appointments possibly signal decreased scrutiny on biopharma M&A President-elect Donald Trump's nomination of Andrew Ferguson and Mark Meador to the Federal Trade Commission signals a potential shift ... READ MORE >
5 things to know in life sciences: Week of December 2, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. How the Trump administration could affect the life sciences industry The incoming Trump administration may promote increased mergers and acquisitions activity in the biopharma sector due to a less restrictive ... READ MORE >